Medicine and Dentistry
Cancer Stem Cell
100%
Oncofetal Antigen
100%
Stem Cell Mobilization
100%
Neoplasm
36%
Stem Cell
27%
Immunotherapy
18%
Chimeric Antigen Receptor T-Cell
9%
Cancer Therapy
9%
Cell Function
9%
Notch
9%
Mesenchymal-Epithelial Transition
9%
Cell Population
9%
Tumor Progression
9%
Recurrent Disease
9%
Carcinogenesis
9%
Epithelial Mesenchymal Transition
9%
Tumor Antigen
9%
Cell Surface Marker
9%
Tumor Initiation
9%
Cell Component
9%
Antibody-Drug Conjugate
9%
Blood Group A Antigen
9%
Superantigen
9%
Vaccinia
9%
Immunology and Microbiology
Oncofetal Antigen
100%
Cancer Stem Cell
100%
Stem Cell
27%
Immunotherapy
18%
Epithelial Mesenchymal Transition
9%
Superantigen
9%
Notch
9%
Cell Population
9%
Cell Function
9%
Cell Surface Marker
9%
Tumor Antigen
9%
Volume
9%
Chimeric Antigen Receptor T-Cell
9%
CXCR4
9%
Modified Vaccinia Ankara
9%
Clonogenesis
9%
Antibody Drug Conjugate
9%
Blood Group A Antigen
9%
Cell Component
9%
Hedgehog
9%
Biochemistry, Genetics and Molecular Biology
Cancer Stem Cell
100%
Oncofetal Antigen
100%
Stem Cell
27%
Notch
9%
Vaccinium
9%
T Cell
9%
Cell Function
9%
CXCR4
9%
Carcinogenesis
9%
Tumor Progression
9%
Volume
9%
Mesenchymal-Epithelial Transition
9%
Conjugate
9%
Tumor Initiation
9%
Tumor Antigen
9%
Cell Surface Marker
9%
Chimeric Antigen Receptor
9%
Blood Group A Antigen
9%
Hedgehog
9%
Clonogenesis
9%